Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Objective: To determine the antiangiogenic effect of cyclosporin A (CSA) in rheumatoid arthritis (RA). Methods: We investigated the effect of CSA on the production of vascular endothelial growth factor (VEGF) by rheumatoid synovial fibroblasts. Fibroblast‐like synoviocytes (FLS) were prepared from the synovial tissues of RA patients, and cultured in the presence of CSA. The production of VEGF by FLS was measured in culture supernatants by enzyme‐linked immunosorbent assay. The VEGF messenger RNA (mRNA) expression and activator protein 1 (AP‐1) binding activity for VEGF transcription were determined by polymerase chain reaction and electrophoretic mobility shift assay, respectively. Results: CSA dose‐dependently inhibited both constitutive and transforming growth factor β‐induced VEGF production at the protein and mRNA levels. The suppressive action of CSA on VEGF synthesis was calcineurin dependent, as evidenced by a comparable inhibition by FK‐506. Agonists of cAMP, 3‐isobutyl‐1‐methylxanthine and N‐2‐O‐dibutyryl‐cAMP, mimicked the effect of CSA on VEGF production, while a cAMP antagonist, 2′,3′‐dideoxyadenosine, abrogated the effect of CSA. A gel mobility shift assay showed that the inhibitory effect of CSA was associated with decreased AP‐1 binding activity to the VEGF promoter, in a cAMP‐dependent manner. Conclusion: CSA may exert an antiangiogenic effect by inhibiting AP‐1‐mediated VEGF expression in rheumatoid synovial fibroblasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., & Alitalo, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37365-9 · Cited by 694
Cited by
Mor, A., Abramson, S. B., & Pillinger, M. H. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.12.009 · Cited by 399
Xia, Y.-P., Li, B., Hylton, D., Detmar, M., Yancopoulos, G. D., & Rudge, J. S. (2003) · Blood · doi:10.1182/blood-2002-12-3793 · Cited by 367
Ali, E. A. I., Barakat, B. M., & Hassan, R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121523 · Cited by 73
“All these factors induce production, migration, and differentiation of macrophages, synovial cells, and endothelial cells [9, 10, 11].”
BackgroundERK1/2 signaling pathways involved in VEGF release in diabetic rat retina
Ye, X., Xu, G., Chang, Q., Fan, J., Sun, Z., Qin, Y., & Jiang, A. C. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4899 · Cited by 47
ERK1/2 signaling pathway in the release of VEGF from Müller cells in diabetes
Ye, X., Ren, H., Zhang, M., Sun, Z., Jiang, A. C., & Xu, G. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-9076 · Cited by 44
Metadata
- Authors
- Cho, M., Cho, C., Min, S., Kim, S., Lee, S., Kim, W., Min, D., Min, J., Youn, J., Hwang, S., Park, S., & Kim, H.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-05
- Volume
- 46
- Issue
- 5
- Pages
- 1202-1209
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1978076384
- Cited by
- 79
- References
- 1
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.